MLYS (Mineralys Therapeutics) Float Percentage Of Total Shares Outstanding: 83.48% (As of Jun. 28, 2026)


MLYS Mineralys Therapeutics Inc MLYS
35 GF Score
Price $26.68
! 1 Warning Sign
View Full Analysis

What is Mineralys Therapeutics Float Percentage Of Total Shares Outstanding?

Mineralys Therapeutics MLYS +1.27% 35 Float Percentage Of Total Shares Outstanding is 83.48% as of Jun. 28, 2026. GuruFocus rates MLYS with a GF Score™ of 35/100. The stock has 1 warning sign investors should review.

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Mineralys Therapeutics's float shares is 73.60 Mil. Mineralys Therapeutics's total shares outstanding is 88.16 Mil. Mineralys Therapeutics's float percentage of total shares outstanding is 83.48%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Mineralys Therapeutics's Insider Ownership is 1.06%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Mineralys Therapeutics's Institutional Ownership is 114.58%.

MLYS
35GF Score
Mineralys Therapeutics Inc MLYS
Float Percentage Of Total Shares Outstanding is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Mineralys Therapeutics Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Mineralys Therapeutics's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=73.60/88.16
=83.48%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Float Percentage Of Total Shares Outstanding of 83.48% mean?
Mineralys Therapeutics (MLYS) has a Float Percentage Of Total Shares Outstanding of 83.48% as of Jun. 28, 2026. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Mineralys Therapeutics and its competitors.
Is Mineralys Therapeutics' Float Percentage Of Total Shares Outstanding too high?
Mineralys Therapeutics' current Float Percentage Of Total Shares Outstanding is 83.48%. Overall, Mineralys Therapeutics has a GF Score™ of 35/100, reflecting its overall financial health beyond just this single metric.
How does Mineralys Therapeutics' Float Percentage Of Total Shares Outstanding compare to IDYA and DFTX?
Mineralys Therapeutics' Float Percentage Of Total Shares Outstanding of 83.48% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Float Percentage Of Total Shares Outstanding for a Biotechnology company?
A good Float Percentage Of Total Shares Outstanding depends on the Biotechnology industry context. However, Float Percentage Of Total Shares Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Float Percentage Of Total Shares Outstanding mean?
A high Float Percentage Of Total Shares Outstanding can signal that a stock is expensive relative to its fundamentals. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Mineralys Therapeutics and its competitors. Mineralys Therapeutics's current Float Percentage Of Total Shares Outstanding is 83.48%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mineralys Therapeutics stock overvalued right now?
Mineralys Therapeutics (MLYS) has a current Float Percentage Of Total Shares Outstanding of 83.48%. The current Float Percentage Of Total Shares Outstanding is 83.48%. Mineralys Therapeutics' overall GF Score™ is 35/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Float Percentage Of Total Shares Outstanding calculated?
Float Percentage Of Total Shares Outstanding is calculated from a company's financial statements. For Mineralys Therapeutics (MLYS), the current Float Percentage Of Total Shares Outstanding is 83.48% as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Mineralys Therapeutics Business Description

Address 150 North Radnor Chester Road, Suite F200, Radnor, PA, USA, 19087
Mineralys Therapeutics Inc is a biopharmaceutical company focused on developing medicines to target diseases driven by dysregulated aldosterone. The Company's product candidate, lorundrostat, is a proprietary, orally administered, aldosterone synthase inhibitor that the Company is developing for the treatment of cardiorenal conditions affected by dysregulated aldosterone, including hypertension and related comorbidities, such as chronic kidney disease and obstructive sleep apnea. Its product candidate, lorundrostat, is a proprietary, orally administered, selective ASI that is designed to reduce aldosterone levels by inhibiting CYP11B2, the enzyme responsible for producing the hormone.
35GF Score

Get the complete analysis for MLYS

Float Percentage Of Total Shares Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$26.68
Price